Name: Entrada Therapeutics, Inc. (TRDA) Balance Sheet
Creator: FinSpry

Entrada Therapeutics Balance Sheet Analysis

Assets, liabilities, and stockholders equity in millions USD

Scale:

Scroll to see more

Balance sheet showing assets, liabilities, and shareholders' equity for Entrada Therapeutics, Inc. (TRDA) - Annual data in millions USD
Breakdown	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020
Current Assets
Cash and Cash Equivalents	101.21	67.60	45.16	291.06	39.05
Short-Term Investments	318.79	284.37	143.56	0.00	0.00
Cash & Short-Term Investments	420.00	67.60	45.16	291.06	39.05
Accounts Receivable	5.48	5.88	0.60	0.00	0.00
Inventory	0.00	0.00	0.00	0.00	0.00
Other Current Assets	14.16	284.37	21.16	7.64	0.90
Total Current Assets	440.04	369.77	209.88	298.70	39.95
Non-Current Assets
Property, Plant & Equipment (Net)	82.05	92.68	33.02	6.26	3.04
Other Non-Current Assets	4.23	6.74	152.72	0.87	0.54
Total Non-Current Assets	86.28	99.42	185.74	7.13	0.00
Total Assets	526.32	469.19	252.06	305.83	43.53
Current Liabilities
Accounts Payable	4.26	18.63	13.57	0.71	1.60
Short-Term Debt	7.56	0.00	0.00	0.00	0.00
Accrued Liabilities	12.30	3.66	2.08	5.53	1.64
Deferred Revenue	13.65	132.26	0.00	0.00	0.00
Other Current Liabilities	1.04	6.66	5.06	0.49	0.12
Total Current Liabilities	39.48	158.80	21.97	6.72	3.36
Non-Current Liabilities
Long-Term Debt	51.65	60.32	17.53	0.00	0.00
Other Non-Current Liabilities	0.00	0.00	0.00	0.40	0.00
Total Non-Current Liabilities	58.16	60.32	17.53	0.40	0.00
Total Liabilities	97.64	226.83	39.50	7.12	3.36
Stockholders' Equity
Common Stock	0.00	0.00	0.00	0.00	0.00
Retained Earnings	-129.34	-194.78	-190.34	-93.67	-42.51
Accumulated Other Comprehensive Income	-0.04	0.20	-2.06	0.00	0.00
Additional Paid-in Capital	558.06	437.13	402.89	392.38	0.00
Shares Outstanding	37.57	33.44	31.39	31.22	0.00
Total Stockholders' Equity	428.68	242.36	212.55	298.72	40.17
Total Liabilities & Equity	526.32	469.19	252.06	305.83	0.00